Discovery of Michael acceptor containing 1, 4-dihydropyridines as first covalent inhibitors of L-/T-type calcium channels HA Cevher, D Schaller, MA Gandini, O Kaplan, E Gambeta, FX Zhang, ... Bioorganic chemistry 91, 103187, 2019 | 18 | 2019 |
Predictive biomarkers of IgA vasculitis with nephritis by metabolomic analysis S Demir, O Kaplan, M Celebier, E Sag, Y Bilginer, I Lay, S Ozen Seminars in Arthritis and Rheumatism 50 (6), 1238-1244, 2020 | 16 | 2020 |
Global omics strategies to investigate the effect of cyclodextrin nanoparticles on MCF-7 breast cancer cells A Ercan, M Çelebier, G Varan, S Öncül, M Nenni, O Kaplan, E Bilensoy European Journal of Pharmaceutical Sciences 123, 377-386, 2018 | 13 | 2018 |
Polycystic ovary syndrome in adolescents: Q-TOF LC/MS analysis of human plasma metabolome M Çelebier, O Kaplan, Ş Özel, Y Engin-Üstün Journal of Pharmaceutical and Biomedical Analysis 191, 113543, 2020 | 10 | 2020 |
Analysis of plasma protein biomarkers in childhood onset multiple sclerosis I Solmaz, E Kocak, O Kaplan, M Celebier, B Anlar Journal of Neuroimmunology 348, 577359, 2020 | 8 | 2020 |
Evaluation of Recent Data Processing Strategies on Q-TOF LC/MS Based Untargeted Metabolomics O Kaplan, M Çelebier Mass Spectrometry Letters 11 (1), 1-5, 2020 | 8 | 2020 |
A combination of Q-TOF LC/MS and LC-MS/MS based metabolomics in pediatric-onset multiple sclerosis demonstrates potential biomarkers for unclassified patients İ SOLMAZ, O KAPLAN, M ÇELEBİER, İ LAY, FB ANLAR Turkish Journal of Medical Sciences 52 (4), 1299-1310, 2022 | 5 | 2022 |
Determination of the Physicochemical Properties of Piroxicam M Celebier, M Nenni, O Kaplan, E Akgeyik, MS Kaynak, S Şahİn Turkish Journal of Pharmaceutical Sciences 17 (5), 535, 2020 | 5 | 2020 |
Effects of genetic polymorphisms of CYP2J2, CYP2C9, CYP2C19, CYP4F2, CYP4F3 and CYP4A11 enzymes in preeclampsia and gestational hypertension MC Ongun, NV Tonyali, O Kaplan, I Deger, M Celebier, NEB Akduman, ... Placenta, 2023 | 3 | 2023 |
Pharmacometabolomic assessment of vitamin E loaded human serum albumin nanoparticles on HepG2 cancer cell lines Y Şenol, O Kaplan, C Varan, N Demirtürk, S Öncül, BB Fidan, A Ercan, ... Journal of Drug Delivery Science and Technology, 104017, 2022 | 2 | 2022 |
Q-TOF LC/MS-based Untargeted Metabolomics Approach to Evaluate the Effect of Folate-Conjugated Cyclodextrins on Triple-Negative Breast Cancer Cells I Varol, O Kaplan, N Erdoğar, S Öncül, TT Nielsen, A Ercan, E Bilensoy, ... Current Pharmaceutical Analysis 17 (10), 1272-1281, 2021 | 2 | 2021 |
Metabolomik Çalismalarin Dünü, Bugünü ve Yarini O Kaplan, M Çelebıer Türkiye Klinikleri. Tip Bilimleri Dergisi 40 (3), 366-374, 2020 | 2* | 2020 |
Assit Ayırıcı Tanısında Assit Metabolom Tayini için Sıvı Kromatografisi Kütle Spektrometrisi Yöntemi Geliştirilmesi O Kaplan Sağlık Bilimleri Enstitüsü, 2017 | 2 | 2017 |
Plasma irisin and metabolomic response differ between concentric and isometric exercise ÖS Kara, A Ercan, M Çelebier, O Kaplan, S Öncül, F Korkusuz Science & Sports, 2022 | 1 | 2022 |
An Isolated Perfused Rat Liver Model: Simultaneous LC-MS Quantification of Pitavastatin, Coproporphyrin I, and Coproporphyrin III Levels in the Rat Liver and Bile N Izat, O Kaplan, M Çelebier, S Sahin ACS omega, 2024 | | 2024 |
Plasma metabolomics for diagnostic biomarkers on ectopic pregnancy O Kaplan, S Ertürk Aksakal, BB Fidan, Y Engin-Üstün, M Çelebier Scandinavian Journal of Clinical and Laboratory Investigation, 1-9, 2024 | | 2024 |
RP-HPLC method combined with ultrafiltration for simultaneous analysis of Melphalan and Topotecan in human plasma samples O Kaplan, N Yılmaz, B Uçar, MÖ Algedik, İ Koç, H Kıratlı, M Çelebier transition 305, 246.0, 2024 | | 2024 |
Development of an RP-HPLC method to evaluate the basic characteristics of talazoparib-loaded PLGA nanoparticles BT Topçu, O Kaplan, SB Pehlivan, M Çelebier, L Öner | | 2024 |
A Plant Metabolomic Approach to Identify the Difference of the Seeds and Flowers Extracts of Carthamus tinctorius L. O Kaplan, N Saltan, A Köse, YB Köse, M Çelebier Mass Spectrometry Letters 14 (2), 42-47, 2023 | | 2023 |
EP78 UNTARGETED METABOLOMICS APPROACH FOR ACUTE PANCREATITIS: SEARCHING FOR POTENTIAL MARKERS USING UPLC-Q-TOF-MS D Turan, M Celebier, O Kaplan, D Ari, BB Fidan, E Ors, CB Agar, A Trak, ... Gastroenterology 164 (6), S-1207-S-1208, 2023 | | 2023 |